Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers
Tsunekazu Oikawa(University of North Carolina at Chapel Hill), Hiromitsu Nakauchi(Japan Science and Technology Agency), Ahn Dong Hyuck(Tokyo University of Science), Lola M. Reid(Institute of Molecular and Cell Biology), Hiromi Chikada(Tokai University), Akihide Kamiya(The University of Tokyo), Eliane Wauthier(University of North Carolina at Chapel Hill), Xin Wei Wang(National Cancer Institute), Yuji Yamazaki(Tokyo University of Science), Lance D. Miller(Genome Institute of Singapore), Hisao Tajiri(Jikei University School of Medicine), Mikio Zeniya(International University of Health and Welfare)
Cited by 195
Related Papers
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer
|Cancer Research|2006|757
Human hepatic stem cells from fetal and postnatal donors
|The Journal of Experimental Medicine|2007|579
Cancer stem cells in the development of liver cancer
|Journal of Clinical Investigation|2013|524